Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-14-002309
Filing Date
2014-04-10
Accepted
2014-04-10 17:09:13
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32014a1_actinium.htm S-3/A 757236
2 FORM OF INDENTURE fs32014a1ex4ii_actinium.htm EX-4.2 462014
3 FORM OF COMMON STOCK WARRANT AGREEMENT AND WARRANT CERTIFICATE fs32014a1ex4iii_actinium.htm EX-4.3 155727
4 FORM OF PREFERRED STOCK WARRANT AGREEMENT AND WARRANT CERTIFICATE fs32014a1ex4iv_actinium.htm EX-4.4 162419
5 FORM OF DEBT SECURITIES WARRANT AGREEMENT AND WARRANT CERTIFICATE fs32014a1ex4v_actinium.htm EX-4.5 139379
6 OPINION OF HISCOCK & BARCLAY, LLP fs32014a1ex5i_actinium.htm EX-5.1 28247
7 CONSENT fs32014a1ex23i_actinium.htm EX-23.1 3654
8 img1.jpg GRAPHIC 37712
9 img2.jpg GRAPHIC 7982
10 img9.gif GRAPHIC 4794
  Complete submission text file 0001213900-14-002309.txt   1779614
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-194768 | Film No.: 14757830
SIC: 6770 Blank Checks